Trusted by the world’s leading institutions

clients clients clients clients clients clients clients clients clients clients clients
Released: 22-Feb-2006 7:00 AM EST
Methodist Neurosurgeon Makes Quantum Leap on Nano-Level
Houston Methodist

A neurosurgeon at the Methodist Neurological Institute (NI) found a new way to label nanotubes using quantum dots, a discovery that could give researchers a new view into cancer cells, proteins, and DNA molecules.

Released: 22-Mar-2006 1:00 PM EST
Tip Sheet: Stroke Awareness Month
Houston Methodist

1) Investigational neuroprotectant for stroke showing positive signs; 2) Investigational NeuroFlo device for ischemic stroke; 3) Interventional stroke treatment uses first FDA-approved brain stent; 4) Implanted pump targets spasticity in stroke patients

Released: 19-Apr-2006 2:55 PM EDT
Music Therapy to Treat Parkinson’s Disease
Houston Methodist

A unique music therapy study, funded by the GRAMMY Foundation, is underway at the Methodist Neurological Institute (NI) in Houston. Dr. Ron Tintner, a neurologist at the NI and a participating physician in Methodist's Center for Performing Arts Medicine program, is studying music as a way to help treat Parkinson's disease patients.

Released: 30-Apr-2006 12:45 PM EDT
Novel Combined Therapy for Prostate Cancer Proves Significantly More Effective
Houston Methodist

A five-year follow-up study finds that a combination of radiation and suicide gene therapy is eliminating the spread of prostate cancer and providing a long term vaccine against the disease.

Released: 24-May-2006 12:00 AM EDT
Study Targets Immune System in Lou Gehrig’s Disease Patients
Houston Methodist

A unique clinical study found only at the Methodist Neurological Institute (NI) in Houston is looking at the benefits of Lipitor on the immune system in patients with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS).

16-Jun-2006 12:00 PM EDT
Biggest Reduction in Bad Cholesterol Ever Achieved in a Clinical Trial
Houston Methodist

Research conducted at the Methodist DeBakey Heart Center in Houston shows a 70 percent reduction in LDL-c, or bad cholesterol, using a combination therapy of two statin drugs. This is the largest reduction in bad cholesterol ever seen in a statin clinical trial.

Released: 30-Jun-2006 8:40 PM EDT
FDA-approval of Lucentis™ for Wet Age-Related Macular Degeneration
Houston Methodist

Research conducted by retina surgeons at The Methodist Hospital has contributed to FDA approval of a new wonder drug for patients affected by one of the leading causes of blindness in people over 60.

Released: 10-Jul-2006 1:45 PM EDT
Clinical Trial Studies Stent Grafts to Treat High-Risk Aortic Aneurysms and Tears
Houston Methodist

A clinical trial under way at The Methodist Hospital in Houston is studying the use of stent grafts to treat thoracic aortic aneurysms in high-risk, emergency situations, such as a ruptured aortic aneurysms or tears in the aorta caused by trauma.

Released: 8-Aug-2006 2:00 PM EDT
A Medical/Health Tip Sheet
Houston Methodist

A medical/health tip sheet from The Methodist Hospital in Houston, covering topics ranging from a new sinus procedure to software that allows physicians to understand blood flow in the brain.

Released: 21-Aug-2006 6:20 PM EDT
Weight Loss and Intimacy-- A Search for Self
Houston Methodist

Patients who undergo significant weight loss often need behavioral and social therapy to address issues around intimacy. This is an aspect of obesity that is rarely discussed.


close
0.90586